U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07615894) titled 'WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)' on May 22.
Brief Summary: This is a prospective, single-center, interventional, phase I, dose-escalation, single-arm study designed to evaluate the safety, tolerability, and preliminary efficacy of intrapleural/intraperitoneal infusion of WSK-IM02 in patients with advanced solid tumors complicated by malignant pleural or peritoneal effusions who have failed standard of care.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Malignant Pleural Effusions
Malignant Ascites
Intervention:
BIOLOGICAL: WSK-IM02
WSK-IM02 is an inje...